Sentences with phrase «for immunobiology»
«Through these observations, we determined that the Lkb1 pathway is responsible for supplying Tregs with energy,» says Ye Zheng, an associate professor in Salk's Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis.
https://www.salk.edu/
(From left) Xudong Li, Ye Zheng and Yuqiong Liang of Salk's Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis
Vanderbilt Center for Immunobiology & Vanderbilt Center for Translational and Clinical Immunology
The work «confirms once again that very likely all mammals can be cloned once the reproductive biology and physiology of the particular species is understood and taken into account,» says developmental biologist Davor Solter of the Max Planck Institute for Immunobiology in Freiburg, Germany.
Not exact matches
Take Kellie Ann Jurado, a postdoctoral scientist in immunobiology at Yale University, who will use the funding for research on the effects of the Zika virus on the nervous system.
The project was led by three scientists: John Harley, MD, PhD, Director of the Center for Autoimmune Genomics and Etiology (CAGE) at Cincinnati Children's and a faculty member of the Cincinnati VA Medical Center; Leah Kottyan, PhD, an immunobiology expert with CAGE; and Matthew Weirauch, PhD, a computational biologist with the center.
Department of Cell Biology and Section of Immunobiology, Ludwig Institute for Cancer Research, Yale University School of Medicine, 333 Cedar Street, Post Office Box 208002, New Haven, CT 06520 — 8002, USA.
«Preventing the degradation of MBD3 protein will make it difficult for myeloma cells to escape this class of drugs,» said senior author Madhav Dhodapkar, professor of immunobiology and chief of the Section of Hematology.
Lukas Flatz is currently senior consultant (OAmbF) at the Clinic for Dermatology and Group Leader at the Institute of Immunobiology, Kantonsspital St.Gallen, St. Gallen, Switzerland.
Participating institutions: Helmholtz Association • CNRS • Institute of Molecular Biotechnology • Research Center for Molecular Medicine of the Austrian Academy of Sciences • VIB - KU Leuven • Friedrich Miescher Institute for Biomedical Research • University of Basel • University of Zurich • Central European Institute of Technology • Max Planck Institute of Immunobiology and Epigenetics • Max Planck Institute for Molecular Genetics • German Cancer Research Center • Max Delbrück Center for Molecular Medicine • German Center for Neurodegenerative Diseases • Helmholtz Zentrum München • Max Planck Institute for Evolutionary Anthropology • Helmholtz Institute of RNA - based Infection Research • Saarland University • Technical University Munich • University of Würzburg • Biotech Research & Innovation Centre • Interdisciplinary Nanoscience Center • University of Copenhagen • Centre for Genomic Regulation • Institut Curie • Université de Montpellier • Inserm • Université Toulouse III — Paul Sabatier • École nationale supérieure des mines de Paris • Institute for Molecular Medicine Finland • The Biomedical Research Foundation, Academy of Athens • Weizmann Institute of Science • Hebrew University • Sapienza — University of Rome • Instituto Nazionale Genetica Molecolare • University of Napoli • University of Padua • University of Milan • European Institute of Oncology • Netherlands Cancer Institute • Radboud University • University Medical Center Utrecht • Hubrecht Institute • Instituto Gulbenkian de Ciência • Institute of Bioorganic Chemistry of the Polish Academy of Sciences • Romanian Center for Systems Immunology • Karolinska Institute • MRC Human Genetics Unit • University of Edinburgh • Wellcome Sanger Institute • The Babraham Institute • European Molecular Biology Laboratory — European Bioinformatics Institute
Funding Research reported in this news release was supported by the National Center for Advancing Translational Sciences (award number 1 - UG3 - NS -105703-01) and the National Institute of Diabetes and Digestive and Kidney Diseases (award number R56DK106202 - 01) of the National Institutes of Health: the Cedars - Sinai Board of Governors Regenerative Medicine Institute; the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; and the Drown Foundation.
We thank D.L. Court (National Cancer Institute) for plasmid pSIM18 for the generation of BAC - transgenic mice; J.G. Cyster (UC San Francisco) for Hy10 mice; E. Hobeika and M. Reth (Max Planck Institute of Immunobiology and Epigenetics) for Mb1 - Cre mice; M. Nussenzweig (The Rockefeller University) for B1 - 8hi mice, anti-DEC205 — OVA and anti-DEC205 — CS; G.D. Victora (Whitehead Institute for Biomedical Research) for gene sets for the gene - set - enrichment analysis; O. Ohara, T. Watanabe and Y. Mochizuki for transcriptome analysis; W. Ise for discussions; M. Tochigi, C. Kawai, A. Arakawa and H. Masuda for technical assistance; P. Burrows for critical reading; and R. Brink for communicating unpublished results.
By integrating the aforementioned observations of FMc in autoimmunity and transplantation immunobiology, we reasoned that allogeneic FMc might provide immune surveillance for breast cancer in parous women.
Funding: This work was supported by the Alliance for Cancer Gene Therapy (R.H.V.), the Onyx and Breezy Foundation (K.U.S.), the Barry and Savannah Poodle Memorial Fund and the Mari Lowe Comparative Oncology Center (N.J.M.), the Immunobiology Program of the Abramson Cancer Center at the University of Pennsylvania (NIH grant P30 CA016520, R.H.V.), and the Oncology Research fund at the Veterinary Hospital of the University of Pennsylvania (K.U.S.).